Entera Bio Ltd.
ENTX
$1.22
$0.021.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.65% | -19.89% | -17.47% | -24.20% | -15.78% |
| Total Depreciation and Amortization | -29.27% | -34.78% | -29.17% | -27.45% | -25.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.54% | 8.46% | 12.90% | 48.43% | 63.25% |
| Change in Net Operating Assets | -55.92% | 1,022.32% | 197.40% | 297.65% | 274.38% |
| Cash from Operations | -42.39% | -8.10% | 12.10% | 9.31% | 15.91% |
| Capital Expenditure | -800.00% | -3,466.67% | -1,560.00% | -700.00% | -83.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -800.00% | -3,466.67% | -1,560.00% | -700.00% | -83.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.83% | 191.14% | 119.53% | 116.87% | 175.23% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 85.07% | 18.89% | 5.51% | 5.68% | 12.24% |
| Cash from Financing | -97.17% | 206.30% | 129.81% | 126.96% | 193.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -175.46% | 367.33% | 1,519.47% | 14,756.72% | 859.28% |